Back to results
US 11,883,488 B2Granted
Therapeutic vaccine for Hepatitis B virus (HBV) using the HBV core antigen
AssigneeAbacus Bioscience, Inc.
InventorsEdward A. Clark, Deborah L. Fuller, Che-Leung Law, Amanda Mak
Life of this patent
Estimating the term…
Abstract
Provided herein are compositions of CD1280 binding proteins and a Hepatitis B virus core antigen (HBcAg) and/or a Hepatitis B virus E antigen (HBeAg), or antigenic fragments or mutants thereof, attached to the CD180 binding protein, and methods for using the compositions to treat or limit the development of hepatitis-B virus (HBV)-related disorders.
Claims21
A nucleic acid encoding a polypeptide comprising an amino acid sequence at least 90% identical to the amino acid sequence of SEQ ID NO:3, residues 1-418.
Dependencies are inferred from the claim text.